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Toll-like receptor (TLR)-1 and TLR2 have been shown to be receptors forMycobacterium
leprae (M. leprae), yet it is unclear whetherM. leprae can signal through alternative TLRs.
Other mycobacterial species possess ligands for TLR4 and genetic association studies
in human populations suggest that people with TLR4 polymorphisms may be protected
against leprosy. Using human embryonic kidney (HEK)-293 cells co-transfected with
TLR4, we demonstrate thatM. leprae activates TLR4. We used human macrophages to
show that M. leprae stimulation of cytokine production is diminished if pre-treated with
TLR4 neutralizing antibody. TLR4 protein expression was up-regulated on macrophages
derived from non-bacillus Calmette-Guerin (BCG) vaccinated healthy volunteers after
incubation withM. leprae, whereas it was down-regulated in macrophages derived from
BCG-vaccinated donors. Finally, pre-treatment of macrophages derived from BCG-naive
donors with BCG reversed the effect of M. leprae on TLR4 expression. This may be
a newly described phenomenon by which BCG vaccination stimulates “non-specific”
protection to the human immune system.
Keywords: bacillus Calmette-Guerin, macrophages,Mycobacterium leprae, signaling, Toll-like receptor-4, trained
immunity, leprosy
INTRODUCTION
Mycobacterium leprae is an acid-fast intracellular Gram-positive bacillus, which shows tropism
for macrophages and Schwann cells. Leprosy is the chronic granulomatous disease caused by
M. leprae which mainly affects the skin and peripheral nerves (Britton and Lockwood, 2004).
Although M. leprae has undergone genome decay and contains large number of pseudogenes
(Cole et al., 2001), comparative genomics revealed genetic diversity to be exceptionally rare
among four differentM. leprae strains, showing remarkable conservation of the genome (99.995%
identity; Singh and Cole, 2011). This suggests that the pathology of leprosy is determined
by the host immune response to M. leprae, resulting in a clinical range from tuberculoid
leprosy through borderline forms to lepromatous leprosy as classified by Ridley and Jopling
(1966). Patients with localized tuberculoid leprosy have few skin lesions, are characterized
by normal cell-mediated immune response, antibodies against M. leprae are not significantly
produced and have very few or no bacilli present in the lesions (Ridley and Jopling, 1966).
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Patients with lepromatous leprosy have defective cell-mediated
immune response (T cell anergy to M. leprae antigens; Godal
et al., 1971) and produce large amounts of antibodies that are
unable to control the multiplication ofM. leprae in multiple skin
lesions (Ridley and Jopling, 1966).
Toll-like Receptors (TLRs) are a family of pattern-recognition
receptors that recognize evolutionarily conserved microbial
ligands that form part of the first line of defense against infections
(Medzhitov et al., 1997). TLRs play a role in the granulomatous
inflammation of leprosy (Krutzik et al., 2003). TLR2-TLR1
heterodimers are considered to mediate cell activation by M.
leprae (Krutzik et al., 2003). The M. leprae genome has been
scanned to reveal 31 lipoproteins that could serve as pathogen-
associated molecular patterns to be recognized by TLR2-
TLR1 heterodimers (Krutzik et al., 2003). Synthetic lipoproteins
activated monocytes and monocyte-derived dendritic cells
through TLR2 (Krutzik et al., 2003). In addition, TLR1 and TLR2
have been shown to be more highly expressed in skin lesions of
patients with tuberculoid leprosy than those with lepromatous
leprosy (Krutzik et al., 2003). The local expression of the type-
1 cytokines such as IFN-γ and IL-12 predominates in tuberculoid
lesions, whereas the type-2 cytokines IL-4 and IL-10 characterize
lepromatous leprosy lesions (Yamamura et al., 1991). Therefore,
the local cytokine environment regulates the expression of
TLR2 and TLR1 (Krutzik et al., 2003), possibly determining
the outcome of the innate immune response against M. leprae
infection.
Although in the study by Krutzik et al. the TLRs being
activated and regulated in leprosy were reported to be TLR2
and TLR1, and the response through TLR4 was described as
weak, however, TLR4 and TLR9 have also been implicated
in recognizing proteins from other mycobacteria such as
Mycobacterium tuberculosis (Means et al., 1999, 2001; Jung
et al., 2006), M. paratuberculosis (Byun et al., 2012) and M.
bovis bacillus Calmette-Guerin (BCG; Fremond et al., 2003).
A genetic association study using a cohort of 441 Ethiopian
leprosy patients and 197 healthy controls reported that two single
nucleotide polymorphisms of TLR4 (896G→A and 1196C→T)
were associated with protection against leprosy (Bochud et al.,
2009). These two polymorphisms have been shown to be
associated with lipopolysaccharide (LPS) hyporesponsiveness
(Arbour et al., 2000), by causing local conformational changes
that may affect ligand binding, folding efficiency, cell surface
expression, and protein stability (Ohto et al., 2012). The
TLR4 896 G→A mutation may affect the interaction of TLR4
with myeloid differentiation factor (MyD88) and TIR-domain-
containing adapter-inducing interferon-β (TRIF) (Figueroa et al.,
2012). In addition, these mutations reduce the levels of functional
TLR4 expression (Prohinar et al., 2010).
Previously, we have shown that gene and protein expression
of TLR2 and TLR4 in skin lesions of Type 1 Reactions, an
inflammatory complication that borderline leprosy patients may
develop affecting skin lesion and nerves, is significantly reduced
during effective corticosteroid treatment (Walker et al., 2012).
This indicates a possible role of TLR4 in leprosy and leprosy
reactions. Although this has been speculated in the past (Hart
and Tapping, 2012), based on previous M. tuberculosis research
findings, no research study has addressed this hypothesis for M.
leprae as yet.
Using primary macrophages from TLR4-deficient mice, it
has been demonstrated that the induction of TNF by M. bovis
BCG is mediated partly by functional TLR4 (Fremond et al.,
2003). Infection of TLR4 mutant mice with BCG showed that
TLR4 signaling may have a critical function in fine tuning of
inflammation during chronic mycobacterial infection (Fremond
et al., 2003). In addition, BCG vaccination may be responsible
for epigenetic modifications of innate immune cells causing
a phenomenon described as trained immunity, an imprinting
“memory” effect which could persist up to a year after BCG
vaccination (Kleinnijenhuis et al., 2012, 2014).
We therefore investigated whether TLR4 may act as a
cell receptor for M. leprae and whether binding to TLR4
leads to signal transduction and downstream activation of
innate immune response pathways. TLR4 is the only TLR
that utilizes both MyD88-dependent and independent (TRIF)
pathways for signaling (Hoebe et al., 2003; Yamamoto et al.,
2003). The classic ligand for TLR4 is LPS of the outer
membrane of Gram-negative bacteria (Poltorak et al., 1998). We
hypothesized firstly that M. leprae activates TLR4, by containing
as yet uncharacterized ligands for TLR4 to those already
described in other pathogens, and secondly that treatment
of macrophages with M. leprae could modify the expression
of TLR4 depending on previous BCG-vaccination. We used
the human embryonic kidney (HEK) 293 Blue TLR4 cell
line and monocyte-derived macrophages from BCG-vaccinated
and non-BCG vaccinated healthy volunteers to test our
hypotheses.
MATERIALS AND METHODS
Human Samples
Participants were part of a register of healthy volunteers working
at the London School of Hygiene & Tropical Medicine. All
individuals provided written informed consent. Whole blood
was collected by an experienced phlebotomist. Each of the
healthy volunteers was classified as BCG-vaccinated or non-
BCG-vaccinated after questioning. The vast majority of the BCG-
vaccinated healthy volunteers were British and were vaccinated
during infancy. Although the BCG status was self-reported,
BCG scars were confirmed by the phlebotomist. None of
the healthy volunteers had a history of mycobacterial disease.
All our volunteers were healthy and were not using any
immunosuppressive or other medication. The BCG-vaccinated
and non-BCG vaccinated groups were matched for age and
sex. The study was approved by the Ethics committee of
the London School of Hygiene & Tropical Medicine (Ethics
Ref: 7090).
M. leprae, BCG, and TLR Ligands
Gamma-irradiated killed M. leprae was obtained from Dr.
Tom Gillis (National Hansen’s Disease Programs, Baton Rouge,
Louisiana, USA). The M. leprae had been propagated in nude
mice, the tissues were NaOH-treated to remove host tissue
contamination. All the Multiplicities of Infection (MOIs) of
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the M. leprae used for stimulations were tested for endotoxin
contamination with the Pierce LAL chromogenic endotoxin
quantitation kit (Rockford, USA) and were all below the limit
of detection of this assay. Live BCG Danish strain SSI was
donated by Dr Helen Fletcher (London School of Hygiene &
Tropical Medicine). Ultrapure LPS from Escherichia Coli K12
strain (InvivoGen, SanDiego, USA) was used as a positive control
ligand for TLR4.
Cell Culture of HEK-Blue-Human TLR4
Cells
HEK 293 Blue human TLR4 (HEK-Blue-hTLR4) cells were
purchased from InvivoGen (San Diego, USA). These HEK-
293 cells were engineered to stably express human TLR4,
MD2/CD14 co-receptor genes that are linked to an embryonic
alkaline phosphatase (SEAP) reporter gene resulting in secretion
of SEAP into the tissue culture supernatant when the TLR4,
MD2/CD14 receptors are ligated. These cells express low
endogenous levels of TLR3 and TLR5. However, TLR3 is a
receptor for viral RNA molecules and TLR5 is a receptor
for flagellated bacteria, therefore these two receptors were not
blocked with any neutralizing antibodies, since neitherM. leprae
nor BCG contain ligands for these receptors. Cells were grown
in standard Dulbecco’s modified Eagle’s medium (DMEM) with
10% fetal bovine serum (FBS) supplemented with 50 U/ml
penicillin, 50 µg/ml streptomycin, 100 µg/ml normocin and
2 mM L-glutamine. When cells were 70–80% confluent, they
were detached by tapping the flask, counted, and suspended
at ∼1.4 × 105 cells per ml in medium containing 10% heat-
inactivated bovine serum. Cells were seeded at ∼2.5 × 104 cells
per well, incubated with DMEM medium alone (control) or
medium containing increasing concentrations of killedM. leprae
for 24 h at 37◦C in a CO2 incubator. Twenty microliters of cell
supernatant was added to 180 µl of QUANTI-Blue (InvivoGen,
San Diego, USA) per well of a flat-bottom 96-well plate and
incubated for 1–3 h. SEAP levels were quantified by reading
the absorbance at 630 nm using a spectrophotometer (MRXII,
DYNATECH).
Antibodies
Mouse anti-human TLR4 neutralizing monoclonal antibody
[clone W7C11, immunoglobulin G1 (IgG1)] was obtained from
InvivoGen (San Diego, USA) and used at a final concentration of
1 µg/ml.
Isolation of Human Peripheral Blood
Mononuclear Cells
Venous blood was drawn from healthy volunteers into sterile
blood collection tubes containing heparin, and peripheral
blood mononuclear cells (PBMC) were isolated by density
centrifugation using Ficoll-Paque (GE Healthcare Life Sciences,
USA).
Culture of Human PBMC, Differentiation
into Macrophages and Stimulations with
Killed M. leprae
Isolated PBMC were incubated overnight at 37◦C in RPMI
medium supplemented with 0.5 U/ml penicillin, 0.5 µg/ml
streptomycin, 10% heat-inactivated fetal bovine serum and
human recombinant Macrophage-Colony Stimulating Factor
(M-CSF; Multinyi Biotec, Cologne, Germany) at a final
concentration of 100 ng/ml and then non-adherent cells were
removed by pipetting off the supernatant. Adherent cells were
washed with Phosphate Buffered Saline (PBS) and detached
by incubation with Accutase enzyme cell detachment medium
(eBioscience, San Diego, USA) and scraping when necessary.
Cells were then plated in 48-well plates at a concentration of
1 × 106 monocytes/ml in fresh RPMI medium as described
above. Cultures were incubated at 37◦C in a humidified, 95%
Air/5% CO2 environment for 7 days in order to differentiate
into macrophages. After 7 days the complete culture medium
was removed and replaced with serum-free RPMI. Cells were
rested for 12 h, before pre-treatment for 2 h with mouse
anti-human TLR4 neutralizing monoclonal antibody (Invivogen,
USA) followed by stimulation with killed M. leprae at multiple
MOIs or LPS for 24 h. The following day cell supernatants were
collected for enzyme-linked immunosorbent assay (ELISA) and
stored at−20◦C. These primarymacrophages differentiated from
human PBMC were stimulated with multiple MOIs of killed
M. leprae because the number of MOIs which would lead to
an increase of the cytokine production was not known. MOIs
> 25 were discontinued because they caused desensitization
of the receptor as demonstrated by a reduction in cytokine
production. All the different MOIs of the same donor were
performed during the same experiment for consistency and the
maximum number of healthy volunteers per experiment was
three.
Enzyme-Linked Immunosorbent Assay
(ELISA)
Sandwich ELISAs were used for detection of IL-6 (ebioscience,
USA), TNF-α (ebioscience, USA), and CXCL10 (R&D systems,
USA) in culture supernatants. Assays were performed as
recommended by the manufacturers. Cytokine concentrations
were determined using standard curves generated from
recombinant cytokines. Triplicate wells were used for the assays.
Fluorescent Activated Cell Sorting
PBMC isolated from non-BCG vaccinated healthy volunteers
as described above were treated with red blood cell (RBC) lysis
buffer (Becton Dickinson, USA). Cells were washed, filtered
and counted and extracellular staining was performed with
mouse anti-human monoclonal CD3-PerCPCy5.5 (eBioscience,
San Diego, USA) and mouse anti-human CD14-Alexa Fluor
488 (Becton Dickinson, USA) in PBS supplemented with
2% FBS and EDTA 0.8 mM for 25 min at +4◦C. The cells
were processed through either BC Moflo XDP (Beckman
Coulter, California) or BD FACSAriaIII (Becton Dickinson,
San Jose, California) high speed cell sorters at Flow Cytometry
Core Facility at the Institute of Child Health, University
College London. Sorting the monocyte population from one
sample required at least 3 h using any of the two cell sorters
and therefore in order to process samples from two healthy
volunteers during every experiment, we used concurrently
both cell sorters. Monocytes were considered the cells which
were CD3−CD14+. Single colored-stained CD3+ and CD14+
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cells were used as controls for gating the CD3−CD14+
monocytes. Single stained CD3+ and CD14+ CompBeads
(Becton Dickinson, USA) were used as compensation
controls.
Culture of Monocytes Sorted by Flow
Cytometry, Differentiation into
Macrophages and Stimulation with BCG
and/or M. leprae
Flow cytometry cell-sorted monocytes were plated in T75
flasks containing RPMI medium supplemented with 20% FBS,
0.5 U/ml penicillin, 0.5 µg/ml streptomycin, and human
recombinant M-CSF (Multinyi Biotec, Cologne, Germany) at a
final concentration of 100 ng/ml and incubated at 37◦C for 7
days until differentiation. Non-adherent cells were removed by
pipetting the supernatant. Adherent macrophages were detached
using Accutase enzyme cell detachment medium (eBioscience,
San Diego, USA) and washed. Macrophages were then re-plated
in 24-well plates at a concentration of 2.5× 105 macrophages/ml
in fresh RPMI supplemented with 5% heat-inactivated FBS and
left to rest for 2 h. Half of the macrophages from each donor
remained unstimulated and the other half were stimulated with
BCG at MOI = 10 for 18 h. After 18 h the culture media
was replaced with fresh RPMI supplemented with 5% FBS
and left to rest for 8 h. Both the untreated and the BCG-
treated macrophages were subsequently treated or not with killed
irradiated M. leprae at MOI = 5 or MOI = 10 or LPS 100
ng/ml for 18 h. Adherent macrophages were removed by addition
of Accutase enzyme cell detachment medium (eBioscience, San
Diego, USA) for 25 min followed by washing and they were
transferred into 5 ml Falcon tubes for multicolor flow cytometry
staining.
Multicolor Flow Cytometry
Detached macrophages in 5 ml Falcon tubes were centrifuged
at 800 g for 10 min. Supernatant was decanted and the cell
pellet re-suspended in PBS/10% human AB serum for 10
min. Extracellular staining was performed using mouse anti-
human CD3-PerCPCy5.5 (Becton Dickinson; USA), mouse anti-
human CD14-V450 (Becton Dickinson; USA), mouse anti-
human CD16-APC-Cy7 (Becton Dickinson; USA), and live/dead
stain (FITC; Invitrogen; USA) in FACS buffer (filter sterilized PBS
containing 2% NaN3 and 1% heat-inactivated FBS) for 25 min at
+4◦C.Macrophages were fixed with 4% Paraformaldehyde for 15
min at+4◦C. Cells were permeabilized using PermWash solution
(Becton Dickinson; USA) for 15 min at Room Temperature
(RT) followed by intracellular staining with mouse anti-human
CD68-APC (Biolegend; San Diego, USA) and mouse anti-
human TLR4-PE (ebioscience; San Diego, USA) for 25 min at
+4◦C. Cells were suspended in FACS buffer before acquiring
at least 100,000 events (singlet cells) on a LSRII flow cytometer
(Becton Dickinson; USA). Our panel was multicolor, therefore
CompBeads (Becton Dickinson; USA) and Fluorescence minus
one (FMO) controls were employed throughout to control for
multicolor flow cytometry and for antibody isotype controls (e.g.,
mouse anti-human TLR4-PE isotype control), which were run on
the flow cytometer each time we performed an experiment on the
same day as the samples. The FACS gating strategy was: R1 =
singlets, cells, live cells, CD3− cells, CD68+ cells (macrophages)
and TLR4 expression on CD68+ macrophages. Two subgroup
analyses for TLR4 expression on CD14+CD68+ macrophages
and CD16+CD68+ macrophages were also performed. Data
were analyzed using FlowJo v9 (Tree Star, Oregon, USA). TLR4
expression on CD68+macrophages were displayed as histograms
from which the Median Fluorescence Intensity (MFI) was
derived. Graphs of MFI and their percentage change compared
to unstimulated control (medium) were plotted using GraphPad
Prism 6.0.
Statistical Methods
All statistical analyses were performed using GraphPad Prism 6.0.
Non-parametric Wilcoxon signed-rank tests and Mann-Whitney
tests were used for comparisons. A parametric t-test was used for
the comparisons of the HEK-Blue-hTLR4 cell line experiment.
Values of p < 0.05 were considered significant.
RESULTS
M. leprae Binds to TLR4 Leading to Signal
Transduction
To determine whether TLR4mediates cell activation byM. leprae,
we used HEK-Blue-hTLR4 cells, co-expressing MD2/CD14, that
report signaling through the TLR4 receptor by the secretion of
alkaline phosphatase. The cell line was stimulated with irradiated
whole M. leprae at increasing MOI for 24 h and the levels
of alkaline phosphatase in the supernatants were determined.
Stimulation of the cell line withM. leprae at MOI= 5, MOI= 10,
MOI= 15 led to highly statistically significant (p≤ 0.0001) dose-
dependent increases in the level of alkaline phosphatase in the
supernatants compared to the unstimulated control (medium;
Figure 1). This effect was lost when M. leprae at high MOI ≥
20 was tested (Figure 1). HEK293 cells are widely used in innate
immunity research as they naturally express very low levels or
no TLRs other than the transfected TLR of interest. However,
to confirm the specificity of M. leprae-TLR4 interaction, we
also blocked this receptor with a monoclonal neutralizing
antibody. Significant production of alkaline phosphatase in
the supernatants seen after stimulation of the cell line with
M. leprae MOI between 5 and 15 was abolished if the cell
line was pre-treated with the monoclonal TLR4 neutralizing
antibody, indicating that this was a TLR4 specific effect
(Figure 1).
Pre-treatment with Neutralizing Antibody
for TLR4 Reduces the Cytokine Production
by Human Macrophages
To test whether activation of TLR4 signaling results in an
inflammatory response, human primary macrophages derived
from differentiated PBMC of healthy volunteers were incubated
with increasing MOI of irradiated whole M. leprae for 24
h. The supernatants were collected and ELISAs for both
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FIGURE 1 | M. leprae signals through TLR4. Human embryonic kidney
(HEK) 293-Blue cell line expressing human TLR4, MD2/CD14 co-receptor
genes and a secreted embryonic alkaline phosphatase (SEAP) reporter gene,
was stimulated with increasing concentrations of killed whole M. leprae for 24
h with or without a monoclonal TLR4 neutralizing antibody (N.A.TLR4). The
levels of alkaline phosphatase in the supernatants were detected in medium
by reading the OD at 630 nm (MOI = Multiplicity of infection). ***p ≤ 0.0001
(student’s t-test) compared to unstimulated control.
MyD88-dependent cytokines (IL-6 and TNF-α) and the MyD88-
independent cytokine CXCL10 (Zughaier et al., 2005), were
performed. In macrophages derived from both BCG-vaccinated
and non-BCG-vaccinated healthy volunteers, incubation withM.
leprae led to a secretion of all three cytokines (Figure 2). Pre-
incubation of the macrophages with neutralizing monoclonal
antibody for TLR4 before stimulation with M. leprae, led to a
significant reduction in the three secreted cytokines, indicating
that the observed TLR4 signal transduction leads to cytokine
production in primary cells (Figure 2).
Stimulation of Human Macrophages with
M. leprae Leads to Modulation of TLR4
Protein Expression
Since expression of TLR by cells has been reported to be affected
by engagement with its ligand, we investigated whether TLR4
protein expression would change after overnight incubation
with M. leprae. BCG contains a TLR4 ligand (Fremond et al.,
2003) and therefore macrophages prepared from PBMC of
BCG-vaccinated and unvaccinated healthy volunteers were
incubated overnight with increasing MOI of killed M. leprae.
TLR4 expression in CD68+ live gated cells was then assessed by
FACS analysis (Figure 3A). Permeabilization of the macrophages
followed by intracellular staining for TLR4, meant that both
intracellular and cell surface levels of TLR4 were detected.
The median baseline TLR4 expression in macrophages derived
from BCG-vaccinated healthy volunteers was similar to the
FIGURE 2 | M. leprae stimulates the production of pro-inflammatory
cytokines in human macrophages partly through TLR4 activation.
Macrophages differentiated from isolated PBMC were treated with neutralizing
antibody for TLR4 (N.A.TLR4) for 2 h followed by incubation for 24 h with killed
M. leprae. Supernatants were collected and ELISAs for pro-inflammatory
cytokines TNF-α, IL-6, and CXCL10 were performed. Graphs (A–C) are
derived from n = 4 non-BCG-vaccinated healthy volunteers (white squares)
and n = 4 BCG-vaccinated healthy volunteers (black squares). Wilcoxon
signed-rank tests were performed for each cytokine and showed significant
reductions in cytokine production by anti-TLR4 neutralizing antibody. Median
reduction in pg/ml for TNF-α = 38.34 (P < 0.01), IL-6 = 29.49 (P < 0.01) and
CXCL10 = 13.19 (P < 0.01).
baseline levels of TLR4 expression by macrophages derived
from non-BCG healthy volunteers (data not shown). We
observed an increase in TLR4 MFI (maximum increase
of 69.71% with M. leprae of MOI = 25) in macrophages
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FIGURE 3 | TLR4 expression in macrophages is modulated in BCG-vaccinated and non-BCG vaccinated healthy volunteers after exposure to killed M.
leprae. (A) Histograms showing up-regulation of TLR4 expression in macrophages from a non-BCG vaccinated volunteer (upper histogram) and down-regulation of
TLR4 expression in macrophages from a BCG-vaccinated healthy volunteer (lower histogram) after incubation with killed M. leprae for 18 h. (B) Percentage change of
Median Fluorescence Intensity (MFI) indicating expression of TLR4 compared to unstimulated control (medium) after incubation of macrophages with increasing
concentrations of killed M. leprae for 18 h. Using multicolor flow cytometry, macrophages were gated as CD68+ cell population. The plot shows the total % change in
TLR4 expression compared to controls in macrophages from non-BCG vaccinated (black boxes) and BCG-vaccinated (gray boxes) healthy volunteers, after
incubation with increasing MOI of killed M. leprae. (C) Subgroup analysis of percentage change of TLR4 MFI for the CD16+CD68+ macrophage population. Graphs
summarize (n = 8) experiments with a total of 14 non-BCG vaccinated healthy volunteers and 10 BCG-vaccinated healthy volunteers. Mann-Whitney tests were used
to compare the non-BCG vaccinated with the BCG-vaccinated donors. *0.01 < p < 0.05; **0.001 < p < 0.01; ***0.0001 < p < 0.001, ****p < 0.0001.
from non-BCG-healthy volunteers (n = 14) after overnight
incubation with M. leprae (this effect was not seen at MOI
= 50; Figure 3B). However, we observed a down-regulation
of TLR4 (maximum 36.45% after overnight incubation with
M. leprae MOI = 5) in macrophages from BCG-vaccinated
healthy volunteers (Figure 3B; Supplementary Image 1).
The difference in TLR4 expression between BCG-vaccinated
and non-BCG-vaccinated healthy volunteers was also seen
when cells were gated on the CD16+CD68+ macrophages
(Figure 3C; Supplementary Image 1).
Pre-treatment of Macrophages with BCG
Reverses the Effect of M. leprae on the
Expression of TLR4
In order to investigate the different effect of killed M. leprae
in macrophages of BCG-vaccinated and unvaccinated healthy
volunteers, we added live BCG tomacrophages before incubation
with M. leprae. Monocytes (CD3−CD14+ PBMC) from non-
BCG healthy volunteers were FACS-sorted to acquire pure
macrophage populations after a week of differentiation, without
the presence of any T-lymphocytes. The macrophages were either
treated with live BCG SSI strain overnight or nothing. The
cells were washed to remove BCG non-incorporated by the
macrophages and left to rest for 8 h before the addition of killed
M. leprae or LPS overnight followed by FACS analysis for TLR4
expression in CD68+ macrophages. Treatment of macrophages
with live BCG alone resulted in a clear down-regulation of TLR4
expression compared to unstimulated control (dotted line in
Figures 4A,B). However, treatment of macrophages with killed
M. leprae or LPS led to a heterogeneous result: macrophages from
certain donors showed an up-regulation of TLR4 expression,
while macrophages of other donors showed a down-regulation
of TLR4 expression. Since our healthy volunteers varied in
exposure to both genetic and environmental factors which could
contribute toward this result, we decided to split them into
two groups based on their responsiveness to LPS, which served
as our positive control being the classical ligand for TLR4.
Therefore, five of the healthy volunteers were considered as
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FIGURE 4 | Exposure to live BCG reverses the modulation of TLR4 expression by M. leprae in macrophages from non-BCG vaccinated healthy
volunteers. Percentage change of Median Fluorescence Intensity (MFI) indicating expression of TLR4 compared to unstimulated control (medium) after incubation of
differentiated human macrophages derived from FACS-sorted monocytes with increasing concentrations of killed M. leprae or LPS for 18 h. Using multicolor flow
cytometry, macrophages were gated as CD68+ cell population. The plot shows the total % change in TLR4 expression compared to control (dashed line) in
macrophages without pre-treatment with BCG (black boxes) and with pre-treatment with BCG MOI = 10 for 18 h (gray boxes), following incubation with MOI = 5 and
MOI = 10 of killed M. leprae or with LPS 100 ng/ml for 18 h. Macrophages showing up-regulation of TLR4 expression after incubation with LPS for 18 h were
considered LPS-responsive (A), whereas macrophages showing down-regulation of TLR4 after incubation with LPS were considered non-LPS responsive (B). Graphs
summarize a total of five non-BCG vaccinated healthy volunteers responsive to LPS (A) and a total of six non-BCG vaccinated healthy volunteers non-responsive to
LPS (B). Wilcoxon signed-rank tests were used to compare the different treatments with unstimulated control (dashed line). *0.01 < p < 0.05; **0.001 < p < 0.01.
LPS-responsive after showing up-regulation of TLR4 expression
when incubated overnight with LPS, while six volunteers were
considered non-LPS responsive since they showed a down-
regulation of TLR4 expression after treatment with LPS. This
subgroup analysis demonstrated that treatment of macrophages
with killed M. leprae shows a similar response to treatment
with LPS. Macrophages from LPS-responsive donors showed up-
regulation of TLR4 after overnight incubation with M. leprae
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whereas macrophages derived from non-LPS responsive donors
showed down-regulation of TLR4 expression. Interestingly, we
observed a reversal of this effect when we incorporated the pre-
treatment with live BCG into this analysis. The LPS-responsive
macrophages after pre-treatment with BCG showed a small
down-regulation of TLR4 expression, but when M. leprae was
also added, they lost their ability to up-regulate TLR4, becoming
“unresponsive” in contrast to the macrophages which did not
have any BCG pre-treatment (Figure 4A). Consequently, the
non-LPS responsive macrophages after treatment with BCG
showed a small down-regulation of TLR4 expression, but when
killed M. leprae was also added, they showed a significant
up-regulation of TLR4 becoming “responsive,” in contrast to
the macrophages without BCG pre-treatment (Figure 4B). The
reversal of the effect of killedM. leprae on the TLR4 expression in
macrophages by BCGwas even more evident when a higher MOI
of killed M. leprae was used, illustrating a dose-responsive effect
(Figures 4A,B).
DISCUSSION
It has been previously demonstrated that TLR1 and TLR2
heterodimers are activated by M. leprae (Krutzik et al., 2003).
We undertook this study in order to investigate the possible
involvement of TLR4 in infection by M. leprae. We have shown
that M. leprae contains a ligand that activates TLR4 leading
to signal transduction. The very low or absent level of TLR2
expression by HEK293 cells suggests that the TLR4/MD2/CD14
complex is necessary and sufficient for this signaling. In
addition, we demonstrated that TLR4 is also engaged in ex-
vivo derived human macrophages, the preferred niche of live
M. leprae. When using a monoclonal neutralizing antibody
against TLR4, the production of pro-inflammatory cytokines
TNF-α, IL-6, and CXCL10 after overnight incubation with
killed M. leprae was consistently diminished. We observed
modulation of TLR4 protein expression after stimulating human
macrophages with killedM. leprae, which appears to be regulated
in the opposite direction in BCG-vaccinated and non-BCG
vaccinated healthy volunteers. Finally, when we added live
BCG to macrophages derived from non-BCG vaccinated healthy
donors followed by addition of killed M. leprae, we observed
a reversal of the effect of M. leprae on the expression of
TLR4.
Our finding thatM. leprae activates TLR4 does not contradict
the study by Krutzik et al. which concluded that among
the TLR homodimers tested, only TLR2 was able to mediate
responsiveness toward M. leprae (Krutzik et al., 2003). In fact,
their results also indicated a 10-fold increase in TLR4 activity
by M. leprae in the transfected HEK cells expressing TLR4
homodimers, but this was not described in the results (Krutzik
et al., 2003). In addition, our findings may explain the results
of a study which showed that in vitro stimulation of human
monocytes with both live and sonicated M. leprae induces
interferon (IFN)-β mRNA and protein (Teles et al., 2013).
The induction of theMyD88-independent/TRIF-dependent gene
IFN-β (Covert et al., 2005; Andersen et al., 2008) further
supports the signaling via the TRIF pathway of TLR4 after
exposure to M. leprae. Teles et al. have shown that IFN-
β and its downstream genes were preferentially expressed in
lepromatous leprosy lesions, whereas IFN-γ was preferentially
expressed in tuberculoid lesions (Teles et al., 2013). Although
IFN-β was found in macrophages and co-localized with CD14,
the presence of TLR4 was not examined (Teles et al., 2013).
These authors suggested that the increase of type I interferon
might be due to intercurrent viral infections (Teles et al.,
2013). A more likely explanation is that signaling through the
TLR4/CD14/MD2 complex leads to the increase in local type
1 interferon production. Our results, showing the activation of
TLR4 by M. leprae, could explain why TLR4, using both MyD88
and TRIF-dependent pathways, induces the secretion of type 1
interferons such as IFN-β. Signaling through TLR4 could shift the
immunological balance from localized to disseminated disease in
leprosy. If this is the case, then our study may have implications
in the treatment of leprosy and other mycobacterial diseases
since the induction of IFN-β responses in lepromatous leprosy
may be blocked by a treatment strategy that directly inhibits
TLR4-TRIF signaling. This may be a more effective strategy
favoring appropriate responses that protect againstmycobacterial
infections.
Although we have demonstratedM. leprae signal transduction
and activation through TLR4, the M. leprae ligand(s) remain
to be determined. The classical ligand for TLR4 is the
LPS which is abundant on the bacterial cell wall of Gram-
negative bacteria (Munford, 2008) and is not found on
mycobacteria. However, mycobacterial glycolipids such as the
lipooligosaccharides (LOS) contain the lipid A portion, which
is responsible for the LPS interaction with TLR4 (Park et al.,
2009). LOS derived from non-related bacterial species such as
Campylobacter jejuni (Stephenson et al., 2013) and Neisseria
meningitidis (Liu et al., 2010) have been demonstrated to be
potent activators of TLR4-mediated immunity. Interestingly,
certain mycobacterial species such as M. marinum (Burguiere
et al., 2005; Rombouts et al., 2009), M. kansasii (Hunter
et al., 1983), M. gastri (Gilleron et al., 1993), and the
Canetti variant of M. tuberculosis (Daffe et al., 1991) contain
LOS.
Other candidate M. leprae ligands binding to TLR4 are the
mycobacterial proline-glutamate (PE)/proline-proline-glutamate
(PPE) proteins. The pe/ppe genes are unique to mycobacteria
and particularly abundant in pathogenic mycobacteria such as
M. tuberculosis (Sampson, 2011), whereas PE/PPE proteins of
M. leprae have been described to be recognized by PBMC
from leprosy patients, stimulating IFN-γ production (Choi
et al., 2013). The M. tuberculosis protein pair PE9 (Rv1088)-
PE10 (Rv1089) has recently been reported to physically interact
to form heterodimers, and the PE9-PE10 complex binds
to and activates TLR4 in human macrophages, resulting in
an increase in the transcript levels of IFN-β and inducing
macrophage apoptosis (Tiwari et al., 2015). The PE9-PE10
complex is, therefore, a newly described apoptosis-inducing
factor which acts through TLR4 and is likely to play a
role in the immune evasion strategies of M. tuberculosis
(Tiwari et al., 2015).
Frontiers in Cellular and Infection Microbiology | www.frontiersin.org 8 July 2016 | Volume 6 | Article 72
Polycarpou et al. Mycobacterium leprae Signals through Toll-Like Receptor-4
Other molecules on M. leprae activating TLR4 could be heat
shock protein-65 (HSP-65; Bulut et al., 2005), chaperonin 60
protein (Cehovin et al., 2010), or adhesion heparin-binding
hemagglutinin (HBHA; Jung et al., 2011). These three molecules
have been shown tomediate TLR4 recognition forM. tuberculosis
(Bulut et al., 2005; Cehovin et al., 2010; Jung et al., 2011; Basu
et al., 2012) and although it has been speculated that M. leprae
could also possess similar TLR4 stimulating qualities by encoding
orthologues of HSP60, HSP65 and HBHA (Hart and Tapping,
2012), the exact ligand onM. leprae leading to activation of TLR4
remains elusive.
We observed modulation of TLR4 protein expression in
macrophages after incubation with killed M. leprae which was
differentially expressed in macrophages derived from BCG-
vaccinated and non-BCG-vaccinated healthy volunteers. This
difference was more obvious when the subgroup analysis
of CD16+CD68+ macrophages was performed. CD16 is a
regulator of the TRIF-dependent TLR4 response in human
monocytes by activating Syk, IFN regulatory factor 3 and
STAT1, resulting in enhanced expression of MyD88-independent
genes (Shalova et al., 2012). The general trend of up-
regulation of TLR4 expression in macrophages derived from
the unvaccinated donors after incubation with low MOI of
M. leprae provides further support of an important role of
TLR4 in leprosy. Interestingly, up-regulation of TLR4 mRNA
in mononuclear leukocytes has been described in patients
with active pulmonary tuberculosis (Chang et al., 2006). Up-
regulation of expression of TLR4 and its co-receptor MD-2
in human mononuclear phagocytes increases responsiveness to
LPS through enhanced phosphorylation of downstream signaling
molecule IRAK and increase of NF-κB DNA binding activity,
leading to enhanced cytokine production (Bosisio et al., 2002).
Although the down-regulation of TLR4 expression observed
after stimulation with very high MOI of M. leprae could be
explained as a desensitization of TLR4, it still remains unclear
why exposure to low MOI of M. leprae in BCG-vaccinated
derived macrophages leads to down-regulation of TLR4. Down-
regulation of TLR4 has been an attributed mechanism of
endotoxin tolerance (Nomura et al., 2000) i.e., macrophages
exposed to LPS become hyporesponsive to a second challenge
with LPS. Therefore, one explanation is that these donors have
been pre-exposed to other TLR4 ligands resulting in LPS-like
TLR4 tolerance. Indeed, the down-regulation of TLR4 could
be an indication of such an endotoxin tolerance effect due
to the early exposure of these donors to the BCG which
contains a ligand for TLR4 (Fremond et al., 2003; Nicolle et al.,
2004).
Our results may suggest an enduring modification of the
donors’ innate immune response due to BCG-vaccination early
in life, creating an imprinting “memory” effect which persists
into adulthood. An explanation of our observations could
be via a monocyte-T lymphocyte interaction (heterologous
immunity) or alternatively due to “trained” immunity: an
immune response describing innate immune responses with
enhancing features seen in human monocytes (Kleinnijenhuis
et al., 2012) and macrophages (Saeed et al., 2014). BCG
may induce epigenetic modifications in monocytes, which can
last up to a year after the BCG-vaccination (Kleinnijenhuis
et al., 2012, 2014). The chromatin mark H3K4me3 results
in higher IL-6, TNF-α and TLR4 expression in monocytes
from BCG-vaccinated individuals, compared to monocytes from
non-BCG vaccinated individuals for at least 3 months after
vaccination (Kleinnijenhuis et al., 2012). In addition, the effects
of BCG vaccination on TLR4 expression and LPS-induced pro-
inflammatory cytokines are long-standing and present for at
least one year (Kleinnijenhuis et al., 2014). BCG vaccination
is expected to affect acquired immunity but our data could
suggest that some years after vaccination, non-specific effects
of BCG vaccination can still be detected. Our result is in
agreement with a recent clinical study from Bangladesh in which
healthy household contacts of leprosy patients who received BCG
vaccination as immunoprophylaxis. Twenty-one (0.4%) of those
vaccinated developed clinical manifestations of leprosy within
12 weeks, suggesting that BCG may unmask subclinical leprosy
(Richardus et al., 2015). This described phenomenon could arise
either from boosting of cell–mediated immunity by homologs of
M. leprae present in BCG or from epigenetic reprogramming of
innate cells described as trained immunity (Kleinnijenhuis et al.,
2012).
The monocyte population can turn over quickly (Yona et al.,
2013), but this does not explain how “trained” monocytes
may be maintained in the human body years after the BCG
vaccination. However, cell reprogramming could take place at
the level of progenitor cells in the bone marrow and innate
immune memory can be transferred via progenitor cells (Yanez
et al., 2013). In addition, histone modifications can persist
through cell division (Gaydos et al., 2014). Moreover, monocytes
differentiating into macrophages undergo substantial epigenetic
changes (Saeed et al., 2014) and the lifespan of the macrophage
could be months to years (Murphy et al., 2008; Wilson et al.,
2010). Interestingly, recent evidence demonstrate that major
tissue-resident macrophage populations are established prior to
birth and maintain themselves subsequently during adulthood
independent of replenishment by blood monocytes (Yona et al.,
2013).
Finally, our observation that ex vivo treatment of a pure
population of non-BCG macrophages with live BCG reverses
whatever effect killed M. leprae has on the TLR4 expression
of these cells, could be another indication that M. leprae acts
through the same receptor as BCG and LPS. We acknowledge
that a limitation of our study is that we did not perform
genetic analysis for TLR4 polymorphisms in our group of healthy
volunteers. In addition, we were not able to address the effect
of latent tuberculosis on our donors, a factor that could also
account for macrophages possibly responding in a different
way after stimulation with M. leprae. Nevertheless, it remains
important that the non-LPS responsive macrophages derived
from half the donors, which did not respond with an up-
regulation of TLR4 expression after contact withM. leprae, when
pre-exposed to live BCG, were transformed into “responsive”
macrophages by up-regulation of their TLR4 expression after
exposure to M. leprae. The question whether this modulation of
TLR4 expression could be anothermechanism by which live BCG
acts on innate immune cells rendering themmore responsive and
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therefore more equipped to fight future exposure to pathogenic
bacteria also acting through TLR4, remains to be further
investigated.
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Supplementary Image 1 | TLR4 expression in macrophages is modulated
in BCG-vaccinated and non-BCG vaccinated healthy volunteers after
exposure to killed M. leprae. Percentage change of Median Fluorescence
Intensity (MFI) indicating expression of TLR4 compared to unstimulated control
(medium) after incubation of macrophages with increasing concentrations of killed
M. leprae for 18 h. Using multicolor flow cytometry, macrophages were gated as
CD68+ cell population. The upper scatter plot shows the total % change in TLR4
expression compared to controls in macrophages from non-BCG vaccinated
(white squares) and BCG-vaccinated (black squares) healthy volunteers, after
incubation with increasing MOI of killed M. leprae. The lower scatter plot shows
the subgroup analysis of percentage change of TLR4 MFI for the CD16+CD68+
macrophage population. Graphs summarize (n = 8) experiments with a total of 14
non-BCG vaccinated healthy volunteers and 10 BCG-vaccinated healthy
volunteers. Mann-Whitney tests were used to compare the non-BCG vaccinated
with the BCG-vaccinated donors. ∗0.01 < p < 0.05; ∗∗0.001 < p < 0.01;
∗∗∗0.0001 < p < 0.001; ∗∗∗∗p < 0.0001.
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